Kenneth T. Mills
2017
In 2017, Kenneth T. Mills earned a total compensation of $2.6M as President and CEO at Regenxbio, a 6% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $278,486 |
|---|---|
| Option Awards | $1,734,200 |
| Salary | $530,450 |
| Other | $15,525 |
| Total | $2,558,661 |
Mills received $1.7M in option awards, accounting for 68% of the total pay in 2017.
Mills also received $278.5K in non-equity incentive plan, $530.5K in salary and $15.5K in other compensation.
Rankings
In 2017, Kenneth T. Mills' compensation ranked 4,334th out of 14,666 executives tracked by ExecPay. In other words, Mills earned more than 70.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,334 out of 14,666 | 70th |
Division Manufacturing | 1,521 out of 5,768 | 74th |
Major group Chemicals And Allied Products | 439 out of 2,074 | 79th |
Industry group Drugs | 336 out of 1,730 | 81st |
Industry Biological Products, Except Diagnostic Substances | 63 out of 316 | 80th |
Source: SEC filing on April 11, 2019.
Mills' colleagues
We found four more compensation records of executives who worked with Kenneth T. Mills at Regenxbio in 2017.